InvestSMART

Starpharma Holdings Limited (ASX: SPL) - Announcements

Current share price for SPL : $0.735 0.005 (0.68%)+

ASX company news and announcements for Starpharma Holdings Limited (SPL) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Starpharma Holdings Limited (SPL) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Starpharma Holdings Limited (SPL), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Starpharma Holdings Limited (SPL)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$309 Australian Microcap Investment Conference presentation 21 Oct 2025 3:30PM $0.300 $0.735 risen by 145%
$309 Change of Director's Interest Notice - R Thomas 21 Oct 2025 11:51AM $0.280 $0.735 risen by 162.50%
$309 Notice of 2025 Annual General Meeting/Proxy Form 13 Oct 2025 9:29AM $0.275 $0.735 risen by 167.27%
$309 Change of Director's Interest Notice - C Maley 6 Oct 2025 9:57AM $0.340 $0.735 risen by 116.18%
$309 Notification of cessation of securities - SPL 6 Oct 2025 9:50AM $0.340 $0.735 risen by 116.18%
$309 RAD: Radiopharm Theranostics Partners with SPL on Research 30 Sep 2025 9:47AM $0.220 $0.735 risen by 234.09%
$309 Research and Option Agreement with Radiopharm Theranostics 30 Sep 2025 9:45AM $0.220 $0.735 risen by 234.09%
$309 Presentation to Accompany License Agreement with Genentech 22 Sep 2025 8:57AM $0.130 $0.735 risen by 465.38%
$309 Starpharma Announces License Agreement with Genentech 22 Sep 2025 8:50AM $0.130 $0.735 risen by 465.38%
$309 Date of Annual General Meeting 2025 17 Sep 2025 3:55PM $0.125 $0.735 risen by 488%
$309 $3.7M R&D Tax Incentive Received 28 Aug 2025 9:30AM $0.130 $0.735 risen by 465.38%
$309 2025 Appendix 4G and Corporate Governance Statement 26 Aug 2025 11:09AM $0.130 $0.735 risen by 465.38%
$309 FY25 Key Financial Results and Annual Report 26 Aug 2025 10:55AM $0.130 $0.735 risen by 465.38%
$309 2025 Annual Report 26 Aug 2025 10:47AM $0.130 $0.735 risen by 465.38%
$309 2025 Appendix 4E Preliminary Financial Report 26 Aug 2025 10:42AM $0.130 $0.735 risen by 465.38%
$309 Quarterly Activities/Appendix 4C Cash Flow Report 31 Jul 2025 9:49AM $0.095 $0.735 risen by 673.68%
$309 Notification of cessation of securities - SPL 8 Jul 2025 8:53AM $0.093 $0.735 risen by 690.32%
$309 Change in substantial holding 4 Jun 2025 8:19AM $0.093 $0.735 risen by 690.32%
$309 Change in substantial holding 3 Jun 2025 4:28PM $0.093 $0.735 risen by 690.32%
$309 Quarterly Activities/Appendix 4C Cash Flow Report 30 Apr 2025 9:33AM $0.094 $0.735 risen by 681.91%
$309 Notification of cessation of securities - SPL 4 Apr 2025 10:05AM $0.093 $0.735 risen by 690.32%
$309 Application for quotation of securities - SPL 4 Apr 2025 10:02AM $0.093 $0.735 risen by 690.32%
$309 Becoming a substantial holder 17 Mar 2025 4:12PM $0.100 $0.735 risen by 635%
$309 Half Yearly Report and Accounts 26 Feb 2025 9:44AM $0.115 $0.735 risen by 539.13%
$309 Quarterly Activities/Appendix 4C Cash Flow Report 29 Jan 2025 10:16AM $0.110 $0.735 risen by 568.18%

26 - 50 of 857 results

Page 2 of 35

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.